Global InfertilityDevices Market, by Product Type (Equipment and Accessories), by Procedure(Assisted Reproductive Technology, Artificial Insemination, Fertility Surgery,and Others), by Gender (Male and Female), by End User (Fertility Centers,Hospitals & Surgical Clinics, Cryobanks, and Others), and by Region (North America,Latin America, Europe, Asia Pacific, Middle East, and Africa), was valued atUS$ 7,104.1 million in 2018, and isexpected to exhibit a CAGR of 8.4% over the forecast period (2019-2027).
Increasing adoption ofcollaborations and partnerships by key players are expected to propel themarket growth over the forecast period. For instance, in October 2019, CarlZeiss Meditec AG entered into a partnership with Kyoto University to increasethe company’s research and development capabilities. Similarly, in November2019, Invo Bioscience announced that they have entered commercializationagreements for the InvoCell in-vivo fertility system in Turkey and Jordan, tosupport the company’s expansion into Middle East.
Rising prevalence of infertilityis expected to boost growth of the infertility devices market over the forecastperiod. For instance, according to the International Journal of Women’s Healthand Reproduction Sciences, in 2018, the global prevalence of infertility was10-15%. According to the same data source, in Iran, couples suffering fromprimary and secondary fertility problems were around 78.4% and 21.6%,respectively in 2018.
Moreover, increasing governmentfunding programs for infertility is further expected to drive the infertilitydevices market growth over the forecast period. For instance, in December 2015,Ontario (Canada) government launched the Ontario Fertility Program to providefunds to help infertile patients to overcome such infertility problems.Moreover, access to funded fertility services was available for all forms ofinfertility (including medical and non-medical infertility), regardless ofgender, sexual orientation, or family status.
* The sample copy includes: Report Summary, Table ofContents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copyof this report: https://www.coherentmarketinsights.com/insight/request-sample/2579
Browse 38 Market Data Tables and29 Figures spread through 214 Pages and in-depth TOC on ‘Infertility DevicesMarket’- Global Forecast to 2027, by Product Type (Equipment and Accessories),by Procedure (Assisted Reproductive Technology, Artificial Insemination,Fertility Surgery, and Others), by Gender (Male and Female), by End User(Fertility Centers, Hospitals & Surgical Clinics, Cryobanks, and Others),and by Region (North America, Latin America, Europe, Asia Pacific, Middle East,and Africa)
expected to hold a dominantposition in the infertility devices market over the forecast period, owing toadoption of growth strategies such as product launches, investments, andfacility expansion by the market players in the region to enhance their marketpresence. For instance, in November 2015, INVO Bioscience, Inc., a medicaldevice company announced that the U.S. Food and Drug Administration (FDA)approved company's De Novo request for INVOcell. INVOcell is the first intravaginal culturesystem that was granted marketing clearance in the U.S.
Moreover, rising adoption ofinorganic growth strategies such as distribution agreement, collaborations, andacquisitions by market players in North America are expected to boost theinfertility devices market growth in the region during the forecast period. Forinstance, in November 2018, Ferring Pharmaceuticals signed an agreement toacquire the exclusive U.S. commercialization rights for the INVOcellintravaginal culture (IVC) system from INVO Bioscience Inc. The system includesthe INVOcell IVC device, retention device, and holding block.
Furthermore, Europe is expectedto witness significant growth in the infertility devices market during theforecast period, owing to favorable reimbursement policies by governments forinfertility treatment. For instance, according to the European Policy Audit onFertility (EPAF) rules, there is 100% coverage for women under 43 years forfour IVF treatments and up to six IUI treatments in France.
Key Takeaways of the InfertilityDevices Market:
The global infertility devices marketis expected to exhibit a CAGR of 8.4% over the forecast period, owing toincreasing adoption of collaborations and acquisition strategies by the marketplayers, and rising products approvals by regulatory organizations. Forinstance, in October 2019, INVO Bioscience, Inc., a medical device companyfocused on creating alternative treatments for patients diagnosed withinfertility, announced about receiving the CE mark for its INVOcell culture andretention device.
Browse ResearchReport: https://www.coherentmarketinsights.com/market-insight/infertility-devices-market-2579
Among product type, equipmentsegment held dominant position in the infertility devices market in 2018, owingto increasing research and innovation in the field of fertility by the researchinstitutes. For instance, in 2018, researcher at Worcester PolytechnicInstitute developed a device named Spartan. The Spartan device helps women toget pregnant with fewer treatment trials in IVF fertilization by selectingfaster and healthier sperm. The Spartan name is the short form of SimplePeriodic Array for Trapping and Isolation. This device uses field ofthree-dimensional posts to create obstacle of array through which sperm passesto outlet. The fastest and healthiest sperm that gets into the outlet are usedfor further IVF (In vitro fertilization) procedure.
Among procedure, AssistedReproductive Technology (ART) procedure segment held dominant position in theinfertility devices market in 2018, owing to increasing innovation anddevelopment in ART. For instance, in 2017, Esco Medical Group launchedSemi-Closed Environment (SCE) IVF device to provide controlled environment,while handling the gamete and embryo in IVF procedure.
Among gender, females segmentheld dominant position in the infertility devices market in 2018, owing torising prevalence of infertility. For instance, according to the data byNational Survey of Family Growth (NSFG) published in 2018 indicates that in theU.S., around 5.5% of all female population were infertile and 6.7% of marriedwomen aged 15 to 44 years were infertile.
Companies operating in the globalinfertility devices market include Carl Zeiss Meditec AG, Thermo FisherScientific Inc., Vitrolife AB, The Baker Company, Inc., The Cooper Companies,Inc., Fujifilm Irvine Scientific, IVFTECH APS, Kitazato Corporation, MedGynProducts, Inc., Rocket Medical plc, SOMATEX Medical Technologies GmbH, CookGroup Incorporated, Esco Micro Pte Ltd, Hamilton Thorne, Ltd, and Art BiotechPvt. LTD
Buy-Now this researchreport: https://www.coherentmarketinsights.com/insight/buy-now/2579
AboutCoherent Market Insights:
CoherentMarket Insights is a prominent market research and consulting firm offeringaction-ready syndicated research reports, custom market analysis, consultingservices, and competitive analysis through various recommendations related toemerging market trends, technologies, and potential absolute dollaropportunity.
ContactUs:
mailto:sales@coherentmarketinsights.com
U.S.Office:
Name: Mr. Shah
CoherentMarket Insights 1001 4th Ave,
# 3200Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
